Involvement of &lt;i&gt;Staphylococcus aureus&lt;/i&gt; in Erysipelas

Denis, Olivier; Simonart, Thierry

doi:10.1159/000089013

Cited by 4 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently also Staphylococcus aureus has been isolated from lesions from bullous erysipelas and the question is whether this bacterium plays an etiological part or whether it is rather a contaminant [17, 18]. Such an increase may be the result of decreased host immunity or increased virulence of the bacteria.…”

Section: Resultsmentioning

confidence: 99%

Epidemiology and Comorbidity of Erysipelas in Primary Care

et al. 2007

View full text Add to dashboard Cite

Background/Aims: Most studies on the epidemiology of erysipelas are done in hospitals, resulting in patient selection. The aim of this study is to determine epidemiological characteristics and comorbidity of erysipelas based on primary care data. Methods: Incidence rate study and nested case-control study. A database containing data from 52 general practices in Flanders, Belgium, with morbidity data on 160,000 different patients in the period 1994–2004. Excess comorbidity was determined in patients with erysipelas in 2004. Results: In the period 1994–2004, the age-standardized incidence of erysipelas increased significantly from 1.88 (95% confidence interval, CI, 1.62–2.13) per 1,000 patients to 2.49 (95% CI 2.24–2.74). Of patients with erysipelas, 16% had one or more recurrences. Local factors such as dermatophytosis, chronic ulcer of the skin, varicose veins of the leg and phlebitis and general disorders such as obesity, non-insulin-dependent diabetes and heart failure increased the risk of erysipelas. Conclusion: The incidence of erysipelas increased from 1994 to 2004. More attention should be paid to local factors such as dermatophytosis to prevent erysipelas.

show abstract

Section: Resultsmentioning

confidence: 99%

Epidemiology and Comorbidity of Erysipelas in Primary Care

et al. 2007

View full text Add to dashboard Cite

show abstract

“…We cannot exclude the possibility of allergic reactions to prosthetic material that would mimic erysipelas, but most cases of ‘allergic cellulitis’ probably correspond to misdiagnosed erysipelas, as the clinical and histological features of the two entities are highly comparable. Due to the importance of such cases where methicillin-resistant staphylococci are a recognized cause of erysipelas [16, 17], strict control of risk factors for erysipelas (e.g. portal of entry, non-steroidal anti-inflammatory drugs) and thorough antibiotic therapy should be carefully assessed before proposing the diagnosis of ‘allergic cellulitis’ to hip prosthesis.…”

Section: Resultsmentioning

confidence: 99%

Does Erysipelas-Like Rash after Hip Replacement Exist?

et al. 2006

View full text Add to dashboard Cite

Background: Orthopaedic implants are known to rarely induce or exacerbate dermatitis in metal-allergic patients. In the late 1990s, hypersensitivity to prosthetic material has been suspected to induce recurrent aseptic localized cellulitis. Patients presented with recurrent eruption of the skin overlying the implant, associated with fever. An aseptic origin of this new syndrome was hypothesized as no evidence of microbial involvement could be found and because antibiotic treatment was apparently inefficient. Observations: We observed 4 similar cases. All patients recovered after suppression of factors predisposing to erysipelas (gluteal portal of entry, anti-inflammatory drugs) and appropriate antibiotic therapy. Discussion: Our conviction is that these manifestations are authentic infectious cellulitis. Delayed thigh erysipelas after hip surgery is a distinctive form of cellulitis, characterized by its unusual topography, its rapid outcome and the possibility to be recurrent.

show abstract